A Systematic Review of Adherence with Medications for Diabetes

Diabetes Care

Volumn 27, Issue 5, 2004, Pages 1218-1224

  Cramer, Joyce A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

AGE DISTRIBUTION; CORRELATION ANALYSIS; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; ELECTRONICS; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH CARE DELIVERY; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIFESTYLE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT MONITORING; PRESCRIPTION; REVIEW; SYSTEMATIC REVIEW; WEIGHT GAIN;

DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES;

EID: 2342652451     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.5.1218     Document Type: Review

References (43)

1. Glasgow RE: Compliance to diabetes regimens: conceptualization, complexity, and determinants. In Patient Compliance in Medical Practice and Clinical Trials. Cramer JA, Spilker B, Eds. New York, Raven Press, 1991, p. 209-224
2. Feinstein AR: On white coat effects and the electronic monitoring of compliance. Arch Intern Med 150:1377-1378, 1990
3. World Health Organization: Report on Medication Adherence. Geneva, World Health Org., 2003
4. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC Jr, Sowers JR: Diabetes and cardiovascular disease: a statement for health care professionals from the American Heart Association. Circulation 100:1134-1146, 1999
5. Pugh MJ, Anderson J, Pogach LM, Berlowitz DR: Differential adoption of pharmacotherapy recommendations for type 2 diabetes by generalists and specialists. Med Care Res Rev 60:178-200, 2003
6. Johnson SB: Methodological issues in diabetes research: measuring adherence. Diabetes Care 15:1658-1667, 1992
7. Morris AD, Boyle DIR, McMahon AD, Greene SA, MacDonald TM, Newton RW, for the DARTS/MEMO Collaboration: Adherence to insulin treatment, glycemic control, and ketoacidosis in insulin-dependent diabetes mellitus. Lancet 350: 1505-1510, 1997
8. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL: How often is medication taken as prescribed? A novel assessment technique. JAMA 261:3273-3277, 1989
9. Cramer JA: Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs 49:321-327, 1995
10. Cramer JA: Medication use by the elderly: enhancing patient compliance in the elderly: role of packaging aids and monitoring. Drugs Aging 12:7-15, 1998
11. Boccuzzi SJ, Wogen J, Fox J, Sung JCY, Shah AB, Kim J: Utilization of oral hypoglycemic agents in a drug-insured U.S. population. Diabetes Care 24:1411-1415, 2001
12. Brown JB, Nichol GA, Glauber HS, Bakst A: Ten-year follow-up of antidiabetic drug use, nonadherence, and mortality in a defined population with type-2 diabetes. Clin Ther 21:1045-1057, 1999
13. Catalan VS, Couture JA, Lelorier J: Predictors of persistence of use with the novel antidiabetic agent acarbose. Arch Intern Med 161:1106-1112, 2001
14. Chiechanowski PS, Katon WJ, Russo JE: Depression and diabetes. Arch Intern Med 160:3278-3285, 2000
15. Dailey G, Kim MS, Lian JF: Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a Medicaid patient population with type 2 diabetes mellitus. Clin Ther 23:1311-1320, 2001
16. Dezii CM, Kawabata H, Tran M: Effects of once daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes. South Med J 95:68-71, 2002
17. Donnan PT, MacDonald TM, Morris AD, for the DARTS/MEMO Collaboration: Adherence to prescribed oral hypoglygemic medication in a population of patents with type 2 diabetes: a retrospective cohort study. Diabet Med 19:279-284, 2002
18. Evans JM, Donnan PT, Morris AD: Adherence to oral hypoglycaemic agents prior to insulin therapy in type 2 diabetes. Diabet Med 19:685-688, 2002
19. Melikian C, White J, Vanderplas A, Dezii CM, Chang E: Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy. Clin Ther 24:460-467, 2002
20. Morningstar BA, Sketris IS, Kephart GC, Sclar DA: Variation in pharmacy prescription refill adherence measures by type of oral antihyperglycaemic drug therapy in seniors in Nova Scotia, Canada. J Clin Pharm Ther 27:213-220, 2002
21. Rajagopalan R, Joyce A, Smith D, Ollendorf D, Murray FT: Medication compliance in type 2 diabetes patients: retrospective data analysis (Abstract). Value Health 6:328, 2003
22. Schectman JM, Nadkarni MM, Voss JD: The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 25: 1015-1021, 2002
23. Sclar DA, Robison LM, Skaer TL, Dickson WM, Kozma CM, Reeder CE: Sulfonylurea pharmacotherapy regimen adherence in a Medicaid population: influence of age, gender, and race. Diabetes Educator 25:531-532, 1999
24. Spoelstra JA, Stolk RP, Heerdink ER, Klungel OH, Erkens JA, Leufkens HGM, Grobbee DE: Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy? Pharmacoepidemiol Drug Safety 12:121-127, 2003
25. Venturini F, Nichol MB, Sung JCY, Bailey KL, Cody M, McCombs JS: Compliance with sulfonylureas in a health maintenance organization: a pharmacy record-based study. Ann Pharmacother 33:281-288, 1999
26. Mason BJ, Matsuyama JR, Jue SG: Assessment of sulfonylurea adherence and metabolic control. Diabetes Educator 21:52-57, 1995
27. Matsuyama JR, Mason BJ, Jue SG: Pharmacists' interventions using electronic medication-event monitoring device's adherence data versus pill counts. Ann Pharmacother 27:851-855, 1993
28. Paes AHP, Bakker A, Soe-Aagnie CJ: Impact of dosage frequency on patient compliance. Diabetes Care 20:1512-1517, 1997
29. Rosen MI, Beauvais JE, Rigsby MO, Salahi JT, Ryan CE, Cramer JA: Neuropsychological correlates of sub-optimal adherence to metformin. J Behav Med 26:349-360, 2003
30. Rosen MI, Rigsby MO, Salahi JT, Ryan CE, Cramer JA, Inzucchi S: Electronic monitoring and counseling to improve medication adherence. Behav Res Therapy. In press
31. Anderson EA, Usher JA: Understanding and enhancing adherence in adults with diabetes. Curr Diabetes Rep 3:141-148, 2003
32. Cramer JA: Partial medication compliance: the enigma in poor medical outcomes. Am J Managed Care 1:45-52, 1995
33. Claxton AJ, Cramer JA, Pierce C: medication compliance: the importance of the dosing regimen. Clin Ther 23:1296-1310, 2001
34. Cramer JA: Consequences of intermittent treatment for hypertension: the case for medication compliance and persistence. Am J Managed Care 4:1563-1568, 1998
35. Avorn J, Monette J, Lacour A, Bohn RL, Monane M, Mogun H, LeLorier J: Persistence of use of lipid-lowering medications: a cross-national study. JAMA 279: 1458-1462, 1998
36. Polonsky WH, Anderson BJ, Lohrer PA, Aponte JE, Jacobson AM, Cole CF: Insulin omission in women with IDDM. Diabetes Care 17:1178-1185, 1994
37. Weissberg-Benchell J, Glasgow AM, Tynan WD, Wirtz P, Turek J, Ward J: Adolescent diabetes management and mismanagement. Diabetes Care 18:77-82, 1995
38. Norris SL, Lau J, Smith SJ, Schmid CH, Engelau MM: Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care 25:1159-1171, 2002
39. Cramer JA, Rosenheck R: Enhancing medication compliance for people with serious mental illness. J Nerv Mental Dis 187:52-54, 1999
40. Burnier M, Schneider MP, Chiolero A, Stubi CL, Brunner HR: Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens 19:335-341, 2001
41. Nides MA, Tashkin DP, Simmons MS, Wise RA, Li VC, Rand CS: Improving inhaler adherence in a clinical trial through the use of the Nebulizer Chronolog. Chest 104:501-507, 1993
42. Menzin J, Langley-Hawthome C, Friedman M, Boulanger L, Cavanaugh R: Potential short-term economic benefits of improved glycemic control: a managed care perspective. Diabetes Care 24:51-55, 2001
43. International Society for Pharmacoeconomics and Outcomes Research, Medication Compliance Special Interest Group [article online], 2003, Available from http://www.ispor.org/sigs/medication.htm. Accessed 17 March 2004